GLOBAL SILODOSIN DUTASTERIDE MARKET

INTRODUCTION

Benign prostatic hyperplasia (BPH) in men is treated with the combination drug silodosin dutasteride. It functions by easing the bladder neck and prostate muscles, making urination simpler. The Food and Drug Administration (FDA) has given this pair of medications approval for the treatment of benign prostatic hyperplasia.

As an alpha-1 blocker, silodosin facilitates easier urine passage by relaxing the muscles in the prostate and bladder neck. A 5-alpha-reductase inhibitor like dutasteride acts by lowering the body's levels of dihydrotestosterone. It is hypothesised that this drop in dihydrotestosterone will cause the prostate to shrink, making urination simpler.

Patients should carefully follow their doctor's recommendations when taking this combo drug. Silodosin dutasteride must be taken exactly as directed because taking more or less than advised can have dangerous negative effects.

Headaches, lightheadedness, nausea, diminished libido, and impotence are some of the common side effects. Allergic responses, breathing issues, facial, lip, or tongue swelling, chest pain, and an irregular heartbeat are examples of more severe side effects.

Patients should also be aware that there is a potential risk of developing prostate cancer while taking this medication. It is important to speak to your doctor about this risk, as well as any other potential risks associated with taking silodosin dutasteride.

 Overall, silodosin dutasteride is an effective medication for treating enlarged prostate. However, it is important to speak to a doctor before taking it to ensure it is suitable for your individual case. Additionally, it is important to follow your doctor’s instructions carefully to avoid any potential side effects.

GLOBAL SILODOSIN DUTASTERIDE MARKET SIZE AND FORECAST

The Global silodosin dutasteride market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

Silodosin Dutasteride from Sun Pharmaceutical Industries Ltd. Silodosin Dutasteride is a combination of two medicines: Silodosin and Dutasteride. Silodosin is an alpha-blocker which works by relaxing the muscles in the bladder neck and prostate.

Dutasteride is a 5-alpha reductase inhibitor which works by blocking the conversion of testosterone to dihydrotestosterone (DHT) in the body. This helps to reduce the size of the enlarged prostate.

Together, they help to improve the flow of urine and reduce symptoms of an enlarged prostate such as difficulty in starting urine flow, weak urine flow, and the need to urinate frequently. This medicine is used to treat benign prostatic hyperplasia (BPH).

Silodosin/Dutasteride (Jalyn) is a prescription medication used to treat benign prostatic hyperplasia (BPH) in men. It is a combination of two active ingredients: silodosin and dutasteride. Silodosin is an alpha-blocker that works by relaxing the muscles in the prostate and bladder neck to improve urine flow and reduce symptoms of BPH.

Dutasteride is a 5-alpha reductase inhibitor that works by blocking the action of an enzyme that is responsible for converting testosterone to dihydrotestosterone (DHT), which can contribute to an enlarged prostate. Manufacturer: GlaxoSmithKline (GSK)

COMPANY PROFILE

• Ranbaxy Laboratories
• Cipla Pharmaceuticals
• Sun Pharmaceuticals
• Dr Reddy's Laboratories 
• Lupin Pharmaceuticals
• Intas Pharmaceuticals
• Cadila Pharmaceuticals
• Wockhardt Pharmaceuticals
• Ajanta Pharma
• Emcure Pharmaceuticals
• Zydus Cadila

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many silodosin dutasteride are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global  silodosin dutasteride  and key vendor selection criteria
3. Where is the silodosin dutasteride manufactured? What is the average margin per unit?
4. Market share of Global  silodosin dutasteride  market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global  silodosin dutasteride  in-house
6. key predictions for next 5 years in Global  silodosin dutasteride  market
7. Average B-2-B  silodosin dutasteride  market price in all segments
8. Latest trends in  silodosin dutasteride  market, by every market segment
9. The market size (both volume and value) of the silodosin dutasteride market in 2023-2030 and every year in between?
10. Production breakup of  silodosin dutasteride  market, by suppliers and their OEM relationship